Article
Nature 437, 699-706 (29 September 2005) | doi:10.1038/nature03998; Received 31 March 2005; Accepted 5 July 2005; Published online 18 September 2005
There is an Erratum (26 January 2006) associated with this document.
Regulated cell-to-cell variation in a cell-fate decision system
Alejandro Colman-Lerner1,3, Andrew Gordon1,3, Eduard Serra1, Tina Chin1, Orna Resnekov1, Drew Endy2, C. Gustavo Pesce1 & Roger Brent1
- The Molecular Sciences Institute, 2168 Shattuck Avenue, Berkeley, California 94704, USA
- Division of Biological Engineering, Massachusetts Institute of Technology, 31 Ames Street, Building 68-580, Cambridge, Massachusetts 02139, USA
- *These authors contributed equally to this work
Correspondence to: Alejandro Colman-Lerner1,3 Correspondence and requests for materials should be addressed to A.C.-L. (Email: colman-lerner@molsci.org), A.G. (Email: gordon@molsci.org) and R.B. (Email: brent@molsci.org).
Abstract
Here we studied the quantitative behaviour and cell-to-cell variability of a prototypical eukaryotic cell-fate decision system, the mating pheromone response pathway in yeast. We dissected and measured sources of variation in system output, analysing thousands of individual, genetically identical cells. Only a small proportion of total cell-to-cell variation is caused by random fluctuations in gene transcription and translation during the response ('expression noise'). Instead, variation is dominated by differences in the capacity of individual cells to transmit signals through the pathway ('pathway capacity') and to express proteins from genes ('expression capacity'). Cells with high expression capacity express proteins at a higher rate and increase in volume more rapidly. Our results identify two mechanisms that regulate cell-to-cell variation in pathway capacity. First, the MAP kinase Fus3 suppresses variation at high pheromone levels, while the MAP kinase Kss1 enhances variation at low pheromone levels. Second, pathway capacity and expression capacity are negatively correlated, suggesting a compensatory mechanism that allows cells to respond more precisely to pheromone in the presence of a large variation in expression capacity.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Human therapeutic proteins from silkwormsNature Biotechnology Research News (01 Jan 2003)
Systems biology Deviations in matingNature News and Views (29 Sep 2005)
See all 7 matches for News And ViewsRESEARCH
MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIOJournal of Cerebral Blood Flow & Metabolism Original Article
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
See all 43 matches for Research
